Literature DB >> 15817881

Platelet degranulation is associated with progression of intima-media thickness of the common carotid artery in patients with diabetes mellitus type 2.

Suzanne Fateh-Moghadam1, Zonyang Li, Simon Ersel, Thomas Reuter, Patrik Htun, Ursula Plöckinger, Wolfgang Bocksch, Rainer Dietz, Meinrad Gawaz.   

Abstract

BACKGROUND: Platelets play a key role in atherogenesis and thromboembolic complications in patients with type 2 diabetes. METHODS AND
RESULTS: We prospectively examined the relationship between systemic platelet activation and progression of carotid wall thickness within 1 year in 105 patients with type 2 diabetes. The intima-media thickness (IMT) of the common carotid artery was measured bilaterally at study entry and after 1 year. Platelet activation was assessed with the use of immunologic markers of platelet activation (CD62P, CD63, and CD40L) and flow cytometry. The prevalence for progression of atherosclerotic carotid disease in this population was 55.2%. We found that platelet degranulation (CD63 and CD40L) correlated with progression of IMT within 1 year (CD63: r=0.231, P=0.022; CD40L: r=0.230, P=0.029). Diabetic patients with progression of IMT had a significantly increased expression of CD63 compared with patients with stable carotid disease (mean intensity of immunofluorescence; median, interquartile range: 17.1 [12.4, 25.8] versus 11.9 [7.7, 19.8]; P=0.004). Multivariate logistic regression analysis revealed that degranulation of platelet CD63 is a predictor for progression of IMT independently of classical cardiovascular risk factors and hemoglobin A1c in diabetic patients (P=0.017).
CONCLUSIONS: Enhanced systemic platelet degranulation is associated with progression of carotid artery disease in type 2 diabetes.

Entities:  

Mesh:

Year:  2005        PMID: 15817881     DOI: 10.1161/01.ATV.0000165699.41301.c5

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  25 in total

1.  High platelet reactivity on clopidogrel therapy correlates with increased coronary atherosclerosis and calcification: a volumetric intravascular ultrasound study.

Authors:  Amala P Chirumamilla; Akiko Maehara; Gary S Mintz; Roxana Mehran; Sunil Kanwal; Giora Weisz; Ahmed Hassanin; Diaa Hakim; Ning Guo; Usman Baber; Robert Pyo; Jeffrey W Moses; Martin Fahy; Jason C Kovacic; George D Dangas
Journal:  JACC Cardiovasc Imaging       Date:  2012-05

Review 2.  Platelets in inflammation and atherogenesis.

Authors:  Meinrad Gawaz; Harald Langer; Andreas E May
Journal:  J Clin Invest       Date:  2005-12       Impact factor: 14.808

3.  Autologous platelet concentrate and vacuum-assisted closure device use in a nonhealing total knee replacement.

Authors:  Myra H Klayman; Cody C Trowbridge; Alfred H Stammers; Gary L Wolfgang; David A Zijerdi; Thomas J Bitterly
Journal:  J Extra Corpor Technol       Date:  2006-03

4.  Human solCD39 inhibits injury-induced development of neointimal hyperplasia.

Authors:  J H F Drosopoulos; R Kraemer; H Shen; R K Upmacis; A J Marcus; E Musi
Journal:  Thromb Haemost       Date:  2009-12-18       Impact factor: 5.249

Review 5.  Clinical implications of platelet-vessel interaction.

Authors:  Fabio Mangiacapra; Emanuele Barbato
Journal:  J Cardiovasc Transl Res       Date:  2012-12-28       Impact factor: 4.132

6.  Impact of inflammatory state and metabolic control on responsiveness to dual antiplatelet therapy in type 2 diabetics after PCI: prognostic relevance of residual platelet aggregability in diabetics undergoing coronary interventions.

Authors:  Tobias Geisler; Karin Mueller; Simon Aichele; Boris Bigalke; Konstantinos Stellos; Patrick Htun; Elena Ninci; Susanne Fateh-Moghadam; Andreas E May; Meinrad Gawaz
Journal:  Clin Res Cardiol       Date:  2010-06-06       Impact factor: 5.460

7.  Association of blood monocyte and platelet markers with carotid artery characteristics: the atherosclerosis risk in communities carotid MRI study.

Authors:  N Matijevic; K K Wu; A G Howard; B Wasserman; W Y-W Wang; A R Folsom; A R Sharrett
Journal:  Cerebrovasc Dis       Date:  2011-04-12       Impact factor: 2.762

8.  Platelets release pathogenic serotonin and return to circulation after immune complex-mediated sequestration.

Authors:  Nathalie Cloutier; Isabelle Allaeys; Genevieve Marcoux; Kellie R Machlus; Benoit Mailhot; Anne Zufferey; Tania Levesque; Yann Becker; Nicolas Tessandier; Imene Melki; Huiying Zhi; Guy Poirier; Matthew T Rondina; Joseph E Italiano; Louis Flamand; Steven E McKenzie; Francine Cote; Bernhard Nieswandt; Waliul I Khan; Matthew J Flick; Peter J Newman; Steve Lacroix; Paul R Fortin; Eric Boilard
Journal:  Proc Natl Acad Sci U S A       Date:  2018-01-31       Impact factor: 11.205

9.  Dual therapy with clopidogrel and aspirin prevents early neurological deterioration in ischemic stroke patients carrying CYP2C19*2 reduced-function alleles.

Authors:  Jing Lin; Zhao Han; Chun Wang; Xingyang Yi; Zhenxiao Chai; Qiang Zhou; Ruyue Huang
Journal:  Eur J Clin Pharmacol       Date:  2018-05-26       Impact factor: 2.953

10.  Aspirin plus clopidogrel may reduce the risk of early neurologic deterioration in ischemic stroke patients carrying CYP2C19*2 reduced-function alleles.

Authors:  Xingyang Yi; Qiang Zhou; Chun Wang; Jing Lin; Zhenxiao Chai
Journal:  J Neurol       Date:  2018-08-20       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.